Mizoram logs 314 fresh Covid infections; caseload at over 16,500

The single-day positivity rate was 9.62 per cent

Coronavirus, medical staff, Rapid antigen testing, RAT
Representational image
Press Trust of India Aizawl
1 min read Last Updated : Jun 19 2021 | 1:56 PM IST

Mizoram's COVID-19 tally rose to 16,750 as 314 people, including over 80 children, have tested positive for the virus, an official said on Saturday.

The fresh cases were reported from various districts with Aizawl registering the highest at 240, followed by Lunglei (27) and Siaha (17), he said.

The single-day positivity rate was 9.62 per cent as the fresh cases were detected from 3,261 sample tests, he said.

Thirteen patients have travel history and the rest 301 were found to have locally contracted the infection, he said.

Of the 314 patients, 160 have developed symptoms of COVID-19, he said.

The state now has 3,816 active COVID-19 cases, while 12,858 people have recovered from the infection.

The COVID-19 death toll in the state so far is 76.

Mizoram has tested 4,49,676 samples for COVID-19 till date.

The COVID-19 recovery rate is 76.76 per cent and the death rate is 0.45 per cent.

According to state immunisation officer Dr Lalzawmi, 3,62,851 people have been administered the first dose of COVID-19 vaccine till Friday and of this 53,517 people have received both doses.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jun 19 2021 | 1:54 PM IST

Next Story